We are live on
!
Find out more
AbCellera Biologics
ABCL
ABCL
170 hedge funds and large institutions have $809M invested in AbCellera Biologics in 2023 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 42 increasing their positions, 50 reducing their positions, and 48 closing their positions.
New
Increased
Maintained
Reduced
Closed
164% more call options, than puts
Call options by funds: $7.78M | Put options by funds: $2.94M
1.98% less ownership
Funds ownership: 45.19% → 43.21% (-2%)
7% less funds holding
Funds holding: 183 → 170 (-13)
16% less repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 50
17% less capital invested
Capital invested by funds: $980M → $809M (-$171M)
21% less first-time investments, than exits
New positions opened: 38 | Existing positions closed: 48
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
Holders
170
Holders Change
-13
Holders Change %
-7.1%
% of All Funds
2.67%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.06%
New
38
Increased
42
Reduced
50
Closed
48
Calls
$7.78M
Puts
$2.94M
Net Calls
+$4.83M
Net Calls Change
-$6.24M
Top Buyers
| 1 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$44.6M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
+$40.9M |
| 3 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$28M |
| 4 |
Millennium Management
New York
|
+$14.1M |
| 5 |
PM
Prosight Management
Dallas,
Texas
|
+$12.3M |
Top Sellers
| 1 |
BlackRock
New York
|
-$69.9M |
| 2 |
HMC
Harvard Management Company
Boston,
Massachusetts
|
-$31M |
| 3 |
State Street
Boston,
Massachusetts
|
-$21.4M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$13.1M |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$10.8M |
